title: Ototoxicity from ototopical aminoglycosides.
authors.affiliation: Department of Otolaryngology, Hospital for Sick Children, Toronto, Ontario.
authors.forename: Y
authors.initials: Y
authors.lastname: Hui
authors.forename: A
authors.initials: A
authors.lastname: Park
authors.forename: W S
authors.initials: WS
authors.lastname: Crysdale
authors.forename: V
authors.initials: V
authors.lastname: Forte
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D001301:Audiometry, Pure-Tone; D003907:Dexamethasone / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005601:Framycetin / Q000009:adverse effects / Q000627:therapeutic use; D005839:Gentamicins / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006096:Gramicidin / Q000009:adverse effects / Q000627:therapeutic use; D006314:Hearing Loss, Conductive / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D008297:Male; D010034:Otitis Media with Effusion / Q000150:complications / Q000188:drug therapy*; D018058:Tympanic Membrane Perforation / Q000209:etiology
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D005839:Gentamicins; D006096:Gramicidin; D005601:Framycetin; D003907:Dexamethasone